cicaprost has been researched along with aprosulate* in 1 studies
1 other study(ies) available for cicaprost and aprosulate
| Article | Year |
|---|---|
[Antithrombotic effects of molsidomine alone and in combination with other antithrombotic agents in a thrombosis model of the microcirculation of the rat].
The antithrombotic effect of Molsidomin and other different antithrombotic agents have been investigated alone and in combinations in a thrombosis model in rats in which mesenteric vessels with a diameter of 20-30 microns were injured by defined argon laser lesions. In this animal thrombosis model all agents showed a significant and dose-dependent antithrombotic effect. A strong additive effect was observed when Molsidomin was infused together with Cicaprost. A similar additive effect was observed after administration Molsidomin together with heparins. The combination of a minimal effective dose of Molsidomin with Aprosulate also had a significant additive effect. After application of Molsidomin together with a TXA2 receptor antagonists a slight additive antithrombotic effect was observed. Topics: Animals; Disaccharides; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epoprostenol; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Infusions, Intravenous; Mesenteric Vascular Occlusion; Microcirculation; Molsidomine; Nitric Oxide; Phenylacetates; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Sulfonamides; Thrombosis | 1991 |